Back
First Advantage Vs. Aligos Therapeutics Industry Stock Comparison
Sell
48
FA
First Advantage
Last Price:
19.51
Seasonality Move:
-2.04%
Buy
72
ALGS
Aligos Therapeutics
Last Price:
33.28
Seasonality Move:
10.65%
Sell
48
First Advantage (FA)
is a Sell
Is First Advantage a Buy, Sell or Hold?
- The current First Advantage [FA] share price is $19.53. The Score for FA is 48, which is 4% below its historic median score of 50, and infers higher risk than normal.
- FA is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
72
Aligos Therapeutics (ALGS)
is a Buy
Is Aligos Therapeutics a Buy, Sell or Hold?
- The current Aligos Therapeutics [ALGS] share price is $33.11. The Score for ALGS is 72, which is 44% above its historic median score of 50, and infers lower risk than normal.
- ALGS is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
FA Stock Price Chart
What is First Advantage's stock price today?
-
The First Advantage share price today is $19.53
The current trend is moderately bullish and FA is experiencing selling pressure, which indicates risk of future bearish movement.
ALGS Stock Price Chart
What is Aligos Therapeutics's stock price today?
-
The Aligos Therapeutics share price today is $33.11
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ALGS is experiencing slight selling pressure.
FA Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.33 | Buy |
Relative Strength Index (14 RSI): | 54.68 | Buy |
Chaikin Money Flow: | -382446 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (18.14 - 19.8) | Buy |
Bollinger Bands (100): | (17.65 - 19.77) | Buy |
ALGS Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 4.85 | Buy |
Relative Strength Index (14 RSI): | 78.88 | Buy |
Chaikin Money Flow: | -127407 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (16.12 - 28.52) | Buy |
Bollinger Bands (100): | (7.57 - 20.11) | Buy |
FA Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 19.78 | Sell |
20-day SMA: | 19.1 | Buy |
50-day SMA: | 18.97 | Buy |
200-day SMA: | 17.39 | Buy |
8-day EMA: | 19.65 | Sell |
20-day EMA: | 19.31 | Buy |
50-day EMA: | 18.99 | Buy |
200-day EMA: | 17.7 | Buy |
ALGS Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 29.4 | Buy |
20-day SMA: | 24.33 | Buy |
50-day SMA: | 15.25 | Buy |
200-day SMA: | 15.91 | Buy |
8-day EMA: | 29.74 | Buy |
20-day EMA: | 24.86 | Buy |
50-day EMA: | 18.75 | Buy |
200-day EMA: | 16.3 | Buy |
First Advantage Earnings Growth & FA Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.01 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.13 per share, and an increase next year of $0.12 per share.
Aligos Therapeutics Earnings Growth & ALGS Earnings Dates
- Analysts estimate an earnings increase this quarter of $2.02 per share, a decrease next quarter of $0.00 per share, an increase this year of $30.89 per share, and a decrease next year of $2.65 per share.
First Advantage Technical Analysis
Nov 29 | Dec 2 | Dec 3 | Dec 4 | Dec 5 | Dec 6 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | |
---|---|---|---|---|---|---|---|---|---|---|
Nov | Dec | |||||||||
29 | 02 | 03 | 04 | 05 | 06 | 09 | 10 | 11 | 12 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Aligos Therapeutics Technical Analysis
Nov 29 | Dec 2 | Dec 3 | Dec 4 | Dec 5 | Dec 6 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | |
---|---|---|---|---|---|---|---|---|---|---|
Nov | Dec | |||||||||
29 | 02 | 03 | 04 | 05 | 06 | 09 | 10 | 11 | 12 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |